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INTRODUCTION
Diabetic retinopathy (DR) is the commonest microvascular complication of 
diabetes and a leading cause of blindness in working age adults. The global 
prevalence of diabetic retinopathy is estimated at 34% and varies from region 
to region.[1] Its prevalence is increasing in Sub Saharan Africa and other low and 
middle income countries, fuelled by the increasing number of people living in 
poverty with diabetes, poor control of blood sugar, lipids and blood pressure as 
well as lack of services for early detection and treatment of DR.[2]
Blindness from DR is preventable through early detection and treatment of the 
sight threatening stages of retinopathy. However, many diabetic patients are not 
aware that they have retinopathy or that it can cause blindness. Patients therefore 
do not present to health care providers until symptoms appear, by which time 
treatment cannot restore lost sight. Symptoms only develop at a late stage in the 
disease and even patients with good diabetic control may develop retinopathy.
Screening diabetic patients for retinopathy enables early detection and referral 
for treatment as well an opportunity for education about those risk factors which 
can be modified by treatment or behavioural change. At a screening examination 
patients can be told of the importance of maintaining normal blood glucose, 
blood pressure and serum lipids as well as regular checks of glycosylated 
haemoglobin (HbA1C) level ensuring that it is below 7%.  
The purpose of this article is to create awareness among health workers and their 
patients that diabetes can cause irreversible blindness through development of 
retinopathy, that we can prevent this type of blindness through regular annual 
examination of those without retinopathy or more frequent examination and 
treatment of those with detected retinopathy and that early screening and 
treatment is cheaper than treating and rehabilitating the blind.   
WHAT IS DIABETIC RETINOPATHY?
Diabetic retinopathy is a microangiopathy affecting retinal capillaries and 
venules that occurs in a response to persistent hyperglycaemia. It also affects the 
small vessels of the heart, kidney and brain as well as those supplying peripheral 
nerves. 
Structural weakness of the wall of the capillaries results in development of 
aneurysms, exudation of plasma fluid and bleeding on the retinal surface.
[3] Intra-retinal fluid can accumulate in the macular and is known as macular 
oedema. Damage to capillary wall also results in occlusion mainly due to platelet 
aggregation. This causes retinal ischemia and results in release of vascular 
endothelial growth factors that stimulate growth of new vessels.[4]  New vessels 
develop on the posterior hyaloid face, the iris and in the angle causing vitreous 
haemorrhage, retinal detachment and neovascular glaucoma.
Diabetic retinopathy progresses through different stages before vision is affected. 
The purpose of screening is to identify those stages that threaten the person’s 
sight and recommend treatment as early as possible.
Stages of diabetic retinopathy
1. Non proliferative diabetic retinopathy (NPDR)
NPDR is the earliest stage of retinopathy and is characterized by presence of 
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micro aneurysms, dot and blot haemorrhages and hard 
exudates (Figure 1a). As retinopathy progresses, more 
severe signs of non-proliferative retinopathy (referred to 
as pre-proliferative diabetic retinopathy) appear. These 
includes cotton wool spots and venous caliber changes 
(venous dilation, segmentation and looping) (Figure 1b). 
When detected early through screening pre-proliferative 
stage of NPDR can be treated to prevent its progression 
to proliferative diabetic retinopathy.   
2. Proliferative diabetic retinopathy (PDR)
This stage is characterized by all the above signs plus new 
vessels growing at the disc or elsewhere (Figure 2a). This is 
a sight threatening stage of retinopathy which can progress 
to intra-retinal and pre-retinal haemorrhages (Figure 2b).
Figure 1a Non proliferative diabetic retinopathy            
(Credit International Council of Ophthalmology Guidelines)
Figure 1b. Pre-proliferative diabetic retinopathy – venous 
looping (Credit International Council of Ophthalmology 
Guidelines)
3. Macula oedema
Hard exudates and haemorrhages in the macula region 
with thickened retina (within 1DD of the fovea) is 
referred to as central macula oedema (DMO) and is a 
threat to vision (Figure 3). Macular oedema can occur 
independently of NPDR or PDR.
4. Sight threatening diabetic retinopathy (STDR)
Detection of macula oedema or proliferative diabetic 
retinopathy or both is a threat to patient’s vision either 
because of haemorrhage, tractional retinal detachment or 
macula oedema. These patients need referral for urgent 
treatment with laser or injection of anti VEGF.
Figure 2a. Proliferative Diabetic Retinopathy                  
(Credit Diabetic retinopathy photos American Academy of 
Ophthalmology)
Figure 2b. Intra-retinal and pre-retinal haemorrhages 
(Credit Diabetic retinopathy photos American Academy of 
Ophthalmology)
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HOW TO SCREEN FOR DIABETIC 
RETINOPATHY
There are two approaches to screening for DR:
Systemic screening is the method applicable in resource 
adequate settings where diabetics can be identified through 
a data base or through their family practitioners who 
maintain adequate records of all diabetics visiting their 
clinics. These patients can then be invited for screening 
examinations at intervals as required by the stage of their 
retinopathy. Screening can also be done in remote areas to 
screen diabetics using mobile equipment.
Opportunistic screening is applicable is resource limited 
settings where screening examination is limited to those 
who can come to a diabetic clinic, ophthalmologist or 
optometry surgeries where they may be examined as 
part of eye examination. In some cases, some of these 
patients can be given a schedule of eye examinations by 
the practitioner. People who live in rural areas or who are 
unable to afford visit to clinics will be missed out.
In either method of screening, the number of people 
with diabetes who will need to be examined need to be 
known. To calculate this we need to know the size of the 
population of those aged 20 years and older in the country 
or district. (available from census records). Then we need 
to know the proportion of this population who have 
diabetes (available from diabetes atlas) lastly we need to 
calculate the proportion of people with diabetes who have 
sight threatening diabetic retinopathy. This is estimated 
to be 10% for low income countries.[5]
A screening examination involves examination of the 
retina through fundoscopy. This usually requires the skill 
of the ophthalmologist or an ophthalmic nurse trained 
in the technique of fundoscopy. Direct ophthalmoscopy 
with a hand-held direct ophthalmoscope is easy and can 
be performed by a trained nurse; however it is not possible 
to see to the periphery with direct ophthalmoscopy 
and some peripheral lesions may be missed.  Use of 
binocular indirect ophthalmoscope or a Slit lamp with 
bio-microscopic lens gives a wide magnified view of the 
fundus and enables assessment of the presence of oedema 
of the macula. The equipment is expensive and the skill of 
the ophthalmologist is required which presents a human 
resource limitation to screening.
Equipment required for screening for diabetic retinopathy:
1. Direct and indirect ophthalmoscope
2. Slit lamp and bio microscopic lens
3. Fundus camera
4. Facilities for fluorescein angiography.
Screening for DR at primary health care level
Depending on the personnel and equipment available, 
fundus examination with a direct ophthalmoscope may 
be possible at this level. Otherwise basic history taking 
and measurement of visual acuity is all that is required for 
referral to be initiated.
Record the following during history taking: patient’s 
age, the age at which diagnosis of diabetes was made, 
duration of diabetes, type of diabetes, current treatment, 
last-recorded blood sugar and glycosylated haemoglobin 
and whether systemic disease such as hypertension, 
heart and kidney disease is present. Weight, height and 
blood pressure should be measured and body mass index 
calculated.
Referral for diabetic retinopathy evaluation at the primary 
care level should be based on the type and duration of 
diabetes. 
1. Refer type 1 diabetics for retinal assessment 5 years after 
initial diagnosis of diabetes. 
2. Refer type 2 diabetics when diagnosis is made as the 
diabetes may have been present for a long time and some 
patients may already have retinopathy at the time of the 
initial diagnosis.
Before referral counsel the patients and give education 
about diabetes and its complication particularly eye 
complications. Patients must know that diabetes can 
affect the eye and can cause blindness, but that the 
blindness from diabetes can be prevented if it is detected 
and treated early. So it is important for patients to come 
for eye examinations, even if they feel well and have good 
vision. Referral to secondary care should include anybody 
with vision less than 6/18 and anyone with features of 
diabetic retinopathy or maculopathy.
Figure 3. Significant macula oedema (hard exudates 
within 1 DD of the fovea) (Credit International Council of 
Ophthalmology Guidelines)
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Screening for DR at secondary level of health care
At this level resources for diagnosis may include an 
ophthalmologist and ophthalmic nurses, and equipment 
such as a slit lamp with bio microscopic lens and an 
indirect ophthalmoscope. There may be a fundus camera 
which is the best equipment for screening for diabetic 
retinopathy as it gives a permanent record of the fundus. 
When a systematic programme of screening is underway in 
a district, the camera can become mobile and take photos 
in the community. Photos are then graded by a multiple 
graders according to internationally agreed standards and 
only those with sight threatening features need to travel to 
the main secondary centre. In South Sudan, there is only 
one such fundus camera available at Buluk eye clinic in 
Juba. However with newer technology such as the PEEK 
adapter it is now possible to take retinal photos with 
mobile phones which may make developing a diabetic 
screening service more feasible and practical.
At this level all the processes undertaken at the primary 
care level are performed and then the patient is examined 
Stage of retinopathy Signs Advice to patients
Background diabetic retinopathy





Diabetes is starting to damage your eyes although your 
vision is still good. return for eye examination within 
12-6 months (12 months in mild retinopathy, 6 months 
in moderate retinopathy) 
Ensure that your blood pressure, glucose, and 
cholesterol are controlled  
Take your medications and, exercise regularly, eat 
a healthy (food plate containing ½ vegetables, ¼ 
carbohydrates and ¼ proteins).
Avoid fizzy drinks
Pre-proliferative diabetic 
retinopathy Severe Non 
proliferative diabetic retinopathy 
(NPDR)
All the above plus cotton 
wool spots, venous 
calibre changes (venous 
dilation, segmentation and 
looping), IRMA
Diabetes has damaged your eyes although your vision 
may still be good. You will need Laser treatment 
to ensure that these changes do not progress to 
proliferative stage which would increase your risk of 
losing vision. Laser treatment will maintain rather than 
improve the current vision
Proliferative diabetic retinopathy All the above plus new 
vessels at the disc (NVD) 
or elsewhere (NVE), Intra-
retinal and pre-retinal 
haemorrhages
Diabetes has damaged your eyes severely and your 
vision has gotten worse. You need urgent treatment to 
prevent further loss of sight.  
Maculopathy
No macula oedema No haemorrhage, 
exudates or retinal 
thickening in the macula 
region
Review in 12 months, maintain normal blood pressure, 
blood sugar and cholester-ol, perform regular exercise 
and eat healthy diet
Non centre involving macula 
oedema
Haemorrhages, hard 
exudates or retinal 
oedema >1DD from centre 
of fovea
Diabetes has damaged your eyes severely. Your vision 
may be good now but it may get worse in future. 
You need laser treat-ment to stop it getting worse. 
Treatment will preserve but not improve  present vision
Centre involving macula oedema
Exudates or retinal 
thickening within 1DD of 
the centre of the fovea
Diabetes has damaged your eyes severely and your 
vision has got worse. You need urgent treatment with 
anti VEFG injections to prevent further loss of sight.  
Table 1. Treatment decisions and patient advice on management of diabetic retinopathy at secondary level
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with a slit lamp with bio microscopy. Any retinopathy 
observed is graded and the patient classified. The main 
intention is to detect signs of sight threatening diabetic 
retinopathy and, if present, refer for treatment.
The two signs of sight threatening diabetic retinopathy 
which must be detected on screening are macula oedema 
and new vessels at the disc or elsewhere. These two lesions 
cause loss of vision in a diabetic patient through retinal 
bleeding and accumulation of fluid at the macula. Patients 
with sight threatening diabetic retinopathy must be 
referred urgently for laser or anti VEGF injections.
To prevent vision loss from PDR laser treatment can be 
applied to the peripheral retina to preserve the central 
retina. This is called pan-retinal photocoagulation. Focal 
or diffuse argon laser is also done for macular oedema. 
Serial monthly intravitreal injections of Anti-VEGF are a 
significant advancement in the care of diabetic eyes but is 
rarely affordable in a low resource setting.
At this level patients are informed about the findings of 
their fundus examination, counselled about the stage of 
the retinopathy and advised what action to take in order 
to protect their sight. Table 1 is adapted from Community 
Eye Health Journal 2015:28(92).[6]
TERTIARY CARE FOR DIABETIC 
RETINOPATHY
Screening for diabetic retinopathy will be unproductive 
unless facilities for surgical treatment of diabetic 
retinopathy are in place. This means availability of 
equipment for Laser, anti VEGF and vitrectomy 
treatment as well as OCT for diagnosis and follow up of 
treatment progress. In South Sudan patients requiring 
treatment for sight threatening diabetic retinopathy have 
to be referred abroad. It may appear an unsurmountable 
obstacle to overcome for a country burdened by infectious 
disease, poverty and wars to even think of putting up such 
a facility, but the cost of these overseas referrals surely 
outweigh that of setting up and maintaining these unit.  
DIABETIC RETINOPATHY IN PREGNANCY
Patients with diabetes who are pregnant or are planning 
to become pregnant should be assessed for retinopathy 
in the first trimester of pregnancy and at 28 weeks of 
gestation if the initial assessment was normal. However, 
if retinopathy was detected at the initial examination then 
another assessment should be scheduled at 16-12 weeks. 
Blood sugar must be controlled at all times during the 
duration of pregnancy. General Practitioners, midwifes 
and obstetricians must refer patients for assessment as 
soon as pregnancy is detected.
MANAGEMENT OF CATARACT IN A 
DIABETIC PATIENT
Cataract is the commonest anterior segment complication 
of diabetes. The majority of patients with diabetes will 
have cataract at some point in the course of diabetes and 
Assessment Signs Decision on surgery
No diabetic retinopathy No retinopathy Proceed with cataract surgery





Proceed with cataract surgery
Severe non proliferative diabetic 
retinopathy
Cotton wool spots, venous 
calibre changes, venous 
loopes
1. Fundus visible: treat with laser before surgery
2. Fundus not visible: Retinal surgeon give endolaser 
immediately after cataract extraction before lens 
implantation 
No retinal surgeon, then administer laser in the 
immediate postoperative period
 
Proliferative diabetic retinopathy New vessels at disc or 
macula
Laser treatment or anti VegF injections before cataract 
sur-gery
Macula oedema Haemorrhage, hard 
exudates or retinal 
thickening 1DD to fovea 
Anti VEGF injections to ideally stabilise before cataract 
extraction but can be done with cataract surgery if 
access to services is limited.
Table 2. Management of cataract in a diabetic with or without diabetic retinopathy
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this will require surgery at some stage. Cataract surgery can 
hasten the progression of diabetic retinopathy especially 
if surgery is complicated by capsule break or vitreous 
loss. Before undertaking cataract extraction in a diabetic 
patient retinal assessment to detect retinopathy should be 
undertaken and a decision taken as shown in Table 2.
RELATIONSHIP OF DIABETIC 
RETINOPATHY TO SYSTEMIC 
CONDITIONS
Patients with proliferative diabetic retinopathy may be 
suffering from heart disease, or nephropathy. They are 
therefore prone to developing renal failure, ischemic heart 
disease and stroke and should be promptly referred for 
ECG, Echo cardiography and renal assessment.
CONCLUSION
The prevalence of diabetes is growing rapidly in resource 
poor countries due to life style changes, migration to 
cities, poverty and lack of health care facilities. Blindness 
due to diabetic retinopathy is also increasing although it is 
a preventable condition. The key to preventing blindness 
is through early detection of retinopathy by screening, 
detection and early treatment of the sight threatening form 
of retinopathy. Health education on the need for regular 
eye examinations even in those without symptoms will 
prevent this needless loss of sight.  Further, patients need 
to know that maintaining a near normal blood glucose, 
stable blood pressure, healthy weight and low cholesterol 
can delay the onset and slow the progression of diabetic 
retinopathy. The Government of South Sudan needs to 
do more to invest in facilities for screening and treatment 
of diabetic retinopathy.
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Other useful resources
• Diabetic retinopathy (DR): management and referral 
• Empowering patients with diabetic retinopathy
• Planning a programme to prevent visual loss from 
diabetic retinopathy
• A3 poster with diabetic retinopathy (DR) grading 
system 
